Nchi: Marekani
Lugha: Kiingereza
Chanzo: NLM (National Library of Medicine)
METHADONE HYDROCHLORIDE (UNII: 229809935B) (METHADONE - UNII:UC6VBE7V1Z)
Hikma Pharmaceuticals USA Inc.
METHADONE HYDROCHLORIDE
METHADONE HYDROCHLORIDE 5 mg
ORAL
PRESCRIPTION DRUG
Methadone Hydrochloride Tablets are indicated for the: Methadone Hydrochloride Tablets are contraindicated in patients with: Risk Summary: Neonatal opioid withdrawal syndrome (NOWS) is an expected and treatable outcome of prolonged use of opioids during pregnancy [see Warnings and Precautions (5.5)] . Pregnant women in methadone maintenance programs may have reduced incidence of obstetric and fetal complications and neonatal morbidity and mortality when compared to women using illicit drugs. Untreated opioid addiction in pregnancy is associated with adverse obstetrical outcomes and risk of continued or relapsing illicit opioid use. These risks should be considered in women treated with Methadone Hydrochloride Tablets for maintenance treatment of opioid addiction. For women treated with Methadone Hydrochloride Tablets for pain severe enough to require daily, around-the-clock, long-term opioid treatment, Methadone Hydrochloride Tablets should be used during pregnancy only if the potential benefit justifies the
Methadone Hydrochloride Tablets USP 5 mg tablets are white, biconvex tablets, scored on one side and product identification “54 210” debossed on the other side. NDC 0054-4570-25: Bottle of 100 Tablets NDC 0054-8553-24: 10x10 Unit-Dose The 10 mg tablets are white, biconvex tablets, scored on one side and product identification “54 142” debossed on the other side. NDC 0054-4571-25: Bottle of 100 Tablets NDC 0054-8554-24: 10x10 Unit-Dose Store at 20º to 25ºC (68º to 77ºF), with excursions permitted between 15º to 30ºC (59º to 86ºF). [See USP Controlled Room Temperature.] Store Methadone Hydrochloride Tablets securely and dispose of properly [see Patient Counseling Information (17)] .
New Drug Application
Hikma Pharmaceuticals USA Inc. ---------- MEDICATION GUIDE Methadone Hydrochloride Tablets USP, CII (meth’ a done hye” droe klor’ ide) Rx only Methadone Hydrochloride Tablets are: • A strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain severe enough to require daily around-the-clock, long-term treatment with an opioid, when other pain treatments such as non-opioid pain medicines or immediate-release opioid medicines do not treat your pain well enough or you cannot tolerate them. • A long-acting opioid pain medicine that can put you at risk for overdose and death. Even if you take your dose correctly as prescribed you are at risk for opioid addiction, abuse, and misuse than can lead to death. • Not for use to treat pain that is not around-the-clock. • Also used to manage drug addiction. Important information about Methadone Hydrochloride Tablets: • Get emergency help right away if you take too many Methadone Hydrochloride Tablets (overdose). When you first start taking Methadone Hydrochloride Tablets, when your dose is changed, or if you take too much (overdose), serious or life-threatening breathing problems that can lead to death may occur. • Taking Methadone Hydrochloride Tablets with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death. • Never give anyone else your Methadone Hydrochloride Tablets. They could die from taking it. Selling or giving away Methadone Hydrochloride Tablets is against the law. • Store Methadone Hydrochloride Tablets securely, out of sight and reach of children, and in a location not accessible by others, including visitors to the home. Do not take Methadone Hydrochloride Tablets if you have: • Severe asthma, trouble breathing, or other lung problems. • A bowel blockage or have narrowing of the stomach or intestines. Before taking Methadone Hydrochloride Tablets, tel Soma hati kamili
METHADONE HYDROCHLORIDE- METHADONE HYDROCHLORIDE TABLET HIKMA PHARMACEUTICALS USA INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE METHADONE HYDROCHLORIDE TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR METHADONE HYDROCHLORIDE TABLETS. METHADONE HYDROCHLORIDE TABLETS, FOR ORAL USE CII INITIAL U.S. APPROVAL: 1947 WARNING: ADDICTION, ABUSE, AND MISUSE; RISK EVALUATION AND MITIGATION STRATEGY (REMS); LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; LIFE- THREATENING QT PROLONGATION; NEONATAL OPIOID WITHDRAWAL SYNDROME; INTERACTIONS WITH DRUGS AFFECTING CYTOCHROME P450 ISOENZYMES; RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; AND TREATMENT FOR OPIOID ADDICTION _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ • • • • • • • • • RECENT MAJOR CHANGES Dosage and Administration (2.5) 10/2019 Warnings and Precautions (5.3, 5.15) 10/2019 INDICATIONS AND USAGE Methadone Hydrochloride Tablets are an opioid agonist indicated for the: 4. METHADONE HYDROCHLORIDE TABLETS EXPOSE USERS TO RISKS OF ADDICTION, ABUSE, AND MISUSE, WHICH CAN LEAD TO OVERDOSE AND DEATH. ASSESS EACH PATIENT’S RISK BEFORE PRESCRIBING, AND MONITOR REGULARLY FOR DEVELOPMENT OF THESE BEHAVIORS AND CONDITIONS. (5.1) TO ENSURE THAT THE BENEFITS OF OPIOID ANALGESICS OUTWEIGH THE RISKS OF ADDICTION, ABUSE, AND MISUSE, THE FOOD AND DRUG ADMINISTRATION (FDA) HAS REQUIRED A RISK EVALUATION AND MITIGATION STRATEGY (REMS) FOR THESE PRODUCTS. (5.2) SERIOUS, LIFE-THREATENING, OR FATAL RESPIRATORY DEPRESSION MAY OCCUR. THE PEAK RESPIRATORY DEPRESSANT EFFECT OF METHADONE OCCURS LATER, AND PERSISTS LONGER THAN THE PEAK ANALGESIC EFFECT. MONITOR CLOSELY, ESPECIALLY UPON INITIATION OR FOLLOWING A DOSE INCREASE. (5.3) ACCIDENTAL INGESTION OF METHADONE HYDROCHLORIDE TABLETS, ESPECIALLY BY CHILDREN, CAN RESULT IN FATAL OVERDOSE OF METHADONE. (5.3) QT INTERVAL PROLONGATION AND SERIOUS ARRHYTHMIA (TORSADES DE POINTE Soma hati kamili